RedHill Biopharma (RDHL) Non-Current Debt (2020 - 2022)
RedHill Biopharma (RDHL) posted quarterly Non-Current Debt of $115.2 million for Q4 2022, up 37.79% year-over-year from $83.6 million in Q4 2021, and up 1.19% quarter-over-quarter from $113.9 million in Q3 2022.
RedHill Biopharma (RDHL) Non-Current Debt (2020 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Non-Current Debt for 3 consecutive years, with $115.2 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Non-Current Debt rose 37.79% year-over-year to $115.2 million; the TTM figure through Dec 2022 stood at $115.2 million (up 37.79% YoY), while the FY2022 annual figure was $115.2 million, up 37.79% from the prior year.
- Non-Current Debt advanced to $115.2 million in Q4 2022 per RDHL's latest filing, from $113.9 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $115.2 million in Q4 2022 and bottomed at $78.2 million in Q1 2020.
- Historically, Non-Current Debt has averaged $87.7 million across 3 years, with a median of $83.3 million in 2021.
- Annual changes were most pronounced in 2021 — Non-Current Debt grew 2.74% — and 2022, when it surged 37.79%.
- RedHill Biopharma's Non-Current Debt stood at $81.4 million in 2020, then climbed by 2.74% to $83.6 million in 2021, then surged by 37.79% to $115.2 million in 2022.
- Business Quant data shows RDHL's Non-Current Debt at $115.2 million in Q4 2022, $113.9 million in Q3 2022, and $85.5 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 115.22 Mn |
| Sep 30, 2022 | 113.86 Mn |
| Jun 30, 2022 | 85.51 Mn |
| Mar 31, 2022 | 86.40 Mn |
| Dec 31, 2021 | 83.62 Mn |
| Sep 30, 2021 | 83.52 Mn |
| Jun 30, 2021 | 83.16 Mn |
| Mar 31, 2021 | 82.52 Mn |
| Dec 31, 2020 | 81.39 Mn |
| Sep 30, 2020 | 80.27 Mn |
| Jun 30, 2020 | 79.19 Mn |
| Mar 31, 2020 | 78.17 Mn |